mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics.

mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics.

Item
http://www.wikidata.org/entity/Q54637612
The mTOR signalling pathway in human cancerSDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanomaA highly recurrent RPS27 5'UTR mutation in melanoma.Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma.Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells.Insights into melanoma: targeting the mTOR pathway for therapeutics.Compound 13, an α1-selective small molecule activator of AMPK, potently inhibits melanoma cell proliferation.Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy.Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modelingHigh frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients.Melanoma treatment in review.Investigation of Novel Regulation of N-myristoyltransferase by Mammalian Target of Rapamycin in Breast Cancer Cells
P2860

mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics.

Item
http://www.wikidata.org/entity/Q54637612
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
mTOR pathway activation in cut ...... rer prognosis characteristics.
@en
mTOR pathway activation in cut ...... rer prognosis characteristics.
@nl
type
label
mTOR pathway activation in cut ...... rer prognosis characteristics.
@en
mTOR pathway activation in cut ...... rer prognosis characteristics.
@nl
prefLabel
mTOR pathway activation in cut ...... rer prognosis characteristics.
@en
mTOR pathway activation in cut ...... rer prognosis characteristics.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
mTOR pathway activation in cut ...... rer prognosis characteristics.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1755-148X.2010.00796.X
P433
P478
P50
P577
P698